Protek boosts revenue 26% to 64.2 bln rubles in Q1
MOSCOW. April 20 (Interfax) - Protek Group saw its consolidated revenue grow by 26% year-on-year to 64.236 billion rubles in Q1, the company said in materials.
Revenue from distribution increased 25% to 54.8 billion rubles, and 16% to 289 million units in physical terms.
Revenue from retail sales increased 32% to 12 billion rubles. A total of 52 new pharmacies were opened and 17 closed in Q1. As of March 31, Protek operated a total of 1,803 pharmacies.
Revenue from production grew 49% to 2.8 billion rubles in monetary terms and 46.5% to 8.85 million units in physical terms.
Sales of its own brand increased 47% to 2.2 billion rubles in Q1.
The Protek group includes CV Protek - the largest wholesale distributer or pharmaceutical goods in Russia, four production companies including Sotex and the Rigla pharmacy chain.
The majority shareholder of OJSC Protek is Vadim Yakunin, who through LLC Protek owns 58.79% of the company and 24.4% directly.
